Published in J Clin Invest on July 01, 1996
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest (2001) 7.20
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest (2005) 4.25
Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2000) 3.62
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol (2011) 2.65
Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods (2009) 2.64
Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One (2009) 2.62
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol (2008) 2.60
Origins and fates of cardiovascular progenitor cells. Cell (2008) 2.55
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res (2012) 2.51
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A (2005) 1.85
A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 1.74
Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog (2009) 1.61
Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res (2008) 1.54
A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells (2007) 1.53
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (2014) 1.49
Comparison of imaging techniques for tracking cardiac stem cell therapy. J Nucl Med (2007) 1.33
MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proc Natl Acad Sci U S A (1999) 1.32
Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31
Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes. J Physiol (2007) 1.29
Opportunities for use of human iPS cells in predictive toxicology. Clin Pharmacol Ther (2011) 1.28
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 1.23
The relevance of non-excitable cells for cardiac pacemaker function. J Physiol (2007) 1.22
Embryonic stem cell differentiation models: cardiogenesis, myogenesis, neurogenesis, epithelial and vascular smooth muscle cell differentiation in vitro. Cytotechnology (1999) 1.22
Derivation and spontaneous differentiation of human embryonic stem cells. J Anat (2002) 1.19
In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc Natl Acad Sci U S A (2000) 1.18
Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech (2009) 1.16
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Global transcriptome analysis of murine embryonic stem cell-derived cardiomyocytes. Genome Biol (2007) 1.15
Lentiviral vectors bearing the cardiac promoter of the Na+-Ca2+ exchanger report cardiogenic differentiation in stem cells. Mol Ther (2008) 1.13
Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev (2010) 1.13
Differentiation of neural lineage cells from human pluripotent stem cells. Methods (2008) 1.13
Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest (2013) 1.11
Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol (2001) 1.11
Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc Natl Acad Sci U S A (2009) 1.10
Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ Res (2014) 1.09
Cardiac tissue engineering for replacement therapy. Heart Fail Rev (2003) 1.09
Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes. Tissue Eng Part A (2008) 1.08
Functional cardiac tissue engineering. Regen Med (2012) 1.07
Regulation of adult hematopoietic stem cells fate for enhanced tissue-specific repair. Mol Ther (2009) 1.05
Monoallelic expression and methylation of imprinted genes in human and mouse embryonic germ cell lineages. Proc Natl Acad Sci U S A (2002) 1.05
Targeted inactivation of alphai2 or alphai3 disrupts activation of the cardiac muscarinic K+ channel, IK+Ach, in intact cells. Proc Natl Acad Sci U S A (1997) 1.05
Heart repair and stem cells. J Physiol (2006) 1.04
N-Cadherin: structure, function and importance in the formation of new intercalated disc-like cell contacts in cardiomyocytes. Heart Fail Rev (2000) 1.02
Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening. Stem Cell Res Ther (2013) 1.01
Hyperpolarization-activated cyclic nucleotide-modulated 'HCN' channels confer regular and faster rhythmicity to beating mouse embryonic stem cells. J Physiol (2007) 1.01
Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLoS One (2013) 1.00
Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis. Basic Res Cardiol (2012) 0.99
Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling. Stem Cells Dev (2012) 0.99
Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS One (2011) 0.99
Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J Tissue Eng Regen Med (2011) 0.99
Generation of diverse neuronal subtypes in cloned populations of stem-like cells. BMC Dev Biol (2008) 0.99
Rhythmic beating of stem cell-derived cardiac cells requires dynamic coupling of electrophysiology and Ca cycling. J Mol Cell Cardiol (2010) 0.99
The tumourigenicity of iPS cells and their differentiated derivates. J Cell Mol Med (2013) 0.98
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther (2011) 0.97
Cardiac applications for human pluripotent stem cells. Curr Pharm Des (2009) 0.97
Disruption of aryl hydrocarbon receptor homeostatic levels during embryonic stem cell differentiation alters expression of homeobox transcription factors that control cardiomyogenesis. Environ Health Perspect (2013) 0.97
Human embryonic stem cells: preclinical perspectives. J Transl Med (2008) 0.96
Stem cells in liver regeneration and therapy. Cell Tissue Res (2007) 0.95
Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet? Mol Ther (2011) 0.94
Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells. Semin Immunopathol (2011) 0.94
Embryonic stem cell-derived cardiomyocytes as a model to study fetal arrhythmia related to maternal disease. J Cell Mol Med (2009) 0.93
Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks. Transl Res (2013) 0.92
Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells. Stem Cell Reports (2014) 0.91
Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium. Exp Mol Med (2010) 0.89
Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression. J Cell Mol Med (2008) 0.89
De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications. Chromosome Res (2015) 0.88
Stem cells: potency, plasticity and public perception. J Anat (2002) 0.87
Embryoid body-mediated differentiation of mouse embryonic stem cells along a hepatocyte lineage: insights from gene expression profiles. Tissue Eng (2006) 0.86
Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr Cardiol (2009) 0.86
Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. Stem Cells Int (2011) 0.86
Human embryonic stem cells for myocardial regeneration. Heart Fail Rev (2003) 0.86
Osteogenic Cells Derived From Embryonic Stem Cells Produced Bone Nodules in Three-Dimensional Scaffolds. J Biomed Biotechnol (2004) 0.86
Immune response to stem cells and strategies to induce tolerance. Philos Trans R Soc Lond B Biol Sci (2007) 0.86
Dioxin exposure disrupts the differentiation of mouse embryonic stem cells into cardiomyocytes. Toxicol Sci (2010) 0.85
Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin. Int J Cardiol (2009) 0.85
Cardiac repair by embryonic stem-derived cells. Handb Exp Pharmacol (2006) 0.85
Endothelial cells regulate cardiomyocyte development from embryonic stem cells. J Cell Biochem (2010) 0.85
Stem cell differentiation: cardiac repair. Cells Tissues Organs (2007) 0.84
Stem cell therapy for cardiac repair. J Cardiovasc Nurs (2009) 0.84
Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci (2007) 0.84
Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening. Stem Cell Rev (2012) 0.84
Coaxing stem cells for skeletal muscle repair. Adv Drug Deliv Rev (2014) 0.84
Cell-based approaches for cardiac repair. Ann N Y Acad Sci (2006) 0.84
Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue. Stem Cell Rev (2009) 0.83
Differentiation-independent fluctuation of pluripotency-related transcription factors and other epigenetic markers in embryonic stem cell colonies. Stem Cells Dev (2011) 0.83
Embryonic Stem Cells as a Model for Cardiac Development and Disease. Drug Discov Today Dis Models (2008) 0.83
Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts. Cardiovasc Pathol (2012) 0.83
Fast and efficient multitransgenic modification of human pluripotent stem cells. Hum Gene Ther Methods (2014) 0.82
Mouse Germ Cell Development in-vivo and in-vitro. Biomark Insights (2007) 0.82
Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.82
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends. Indian J Med Res (2013) 0.82
Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium. PLoS One (2013) 0.82
Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev (2014) 0.81
The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med (2009) 0.81
Evaluation of in vitro cytotoxicity and paracellular permeability of intact monolayers with mouse embryonic stem cells. Toxicol In Vitro (2008) 0.81
Immunological barriers to stem-cell based cardiac repair. Stem Cell Rev (2011) 0.81
The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol (1985) 12.74
Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol (1992) 7.23
Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem (1991) 4.45
Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A (1995) 3.85
Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science (1994) 3.24
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97
Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension (1990) 2.55
Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev (1993) 2.48
Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev (1987) 2.24
Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg (1995) 2.09
The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr Res (1992) 1.72
Transition in cardiac contractile sensitivity to calcium during the in vitro differentiation of mouse embryonic stem cells. J Cell Biol (1994) 1.63
Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest (1993) 1.58
Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. J Biol Chem (1991) 1.56
In vitro chamber specification during embryonic stem cell cardiogenesis. Expression of the ventricular myosin light chain-2 gene is independent of heart tube formation. J Biol Chem (1993) 1.45
Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. Mol Cell Biol (1993) 1.38
Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest (1995) 1.36
DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes. Am J Physiol (1995) 1.21
Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest (1995) 1.18
Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol (1993) 1.14
Cardiomyocyte transfer into the mammalian heart. Cell-to-cell interactions in vivo and in vitro. Ann N Y Acad Sci (1995) 1.06
Transgenic mice in cardiovascular research. Annu Rev Physiol (1993) 1.03
Mouse phospholamban gene expression during development in vivo and in vitro. Circ Res (1992) 0.97
Activation of the gene for type-b natriuretic factor in mouse stem cell cultures induced for cardiac myogenesis. Biochem Biophys Res Commun (1994) 0.93
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A (1991) 5.60
Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res (2000) 4.97
Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res (1998) 3.87
Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol (1996) 3.73
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem (2000) 3.45
Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science (1994) 3.24
Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol (1997) 2.65
Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension (1990) 2.55
Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Oncogene (2000) 2.32
Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J (2000) 2.09
Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest (1997) 2.00
Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res (2001) 1.99
Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res (2000) 1.82
Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol (2000) 1.71
Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem (1999) 1.69
Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett (1999) 1.62
Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest (1993) 1.58
Coexpression of mutant p53 and p193 renders embryonic stem cell-derived cardiomyocytes responsive to the growth-promoting activities of adenoviral E1A. Circ Res (2001) 1.57
Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res (2000) 1.57
Tissue and gene specificity of mouse renin expression. Hypertension (1984) 1.53
Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Physiol (1992) 1.53
Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol (1994) 1.46
Ren-1 and Ren-2 loci are expressed in mouse kidney. Proc Natl Acad Sci U S A (1985) 1.45
Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng (2003) 1.44
Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am J Physiol (1990) 1.36
Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest (1995) 1.36
The mouse Pdgfc gene: dynamic expression in embryonic tissues during organogenesis. Mech Dev (2000) 1.29
Skeletal troponin C reduces contractile sensitivity to acidosis in cardiac myocytes from transgenic mice. Proc Natl Acad Sci U S A (1993) 1.23
Gene expression and atrial natriuretic factor processing and secretion in cultured AT-1 cardiac myocytes. Circulation (1992) 1.23
Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm. J Biol Chem (2000) 1.23
DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes. Am J Physiol (1995) 1.21
Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun (2000) 1.21
Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells). Circ Res (1991) 1.19
There are at least two yeast viral double-stranded RNAs of the same size: an explanation for viral exclusion. Cell (1982) 1.18
Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest (1995) 1.18
Predictions of sediment toxicity using consensus-based freshwater sediment quality guidelines. Arch Environ Contam Toxicol (2001) 1.17
Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period. J Mol Cell Cardiol (1997) 1.16
Expression of tissue-specific Ren-1 and Ren-2 genes of mice: comparative analysis of 5'-proximal flanking regions. Mol Cell Biol (1984) 1.16
A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1). Biochim Biophys Acta (2001) 1.16
Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol (1995) 1.15
Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol (1993) 1.14
Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation (2000) 1.14
Length dependence of Ca2+ sensitivity of tension in mouse cardiac myocytes expressing skeletal troponin C. J Physiol (1995) 1.09
Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology (2001) 1.04
Tumor suppressor gene expression during normal and pathologic myocardial growth. J Biol Chem (1994) 1.04
Conserved regions in defective interfering viral double-stranded RNAs from a yeast virus. J Virol (1986) 0.99
Identification of SV40 large T-antigen-associated proteins in cardiomyocytes from transgenic mice. Am J Physiol (1993) 0.98
Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. J Urol (1998) 0.97
The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis. Cardiovasc Res (2001) 0.96
Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene. Circ Res (2000) 0.95
Cloning of cDNA to a yeast viral double-stranded RNA and comparison of three viral RNAs. Gene (1982) 0.95
Stimulation of proliferative events in the adult amphibian cardiac myocyte. Ann N Y Acad Sci (1995) 0.94
Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol (1985) (1993) 0.94
Characterization and expression of a novel alternatively spliced human angiopoietin-2. J Biol Chem (2000) 0.93
Cellular therapies for myocardial infarct repair. Cold Spring Harb Symp Quant Biol (2002) 0.91
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor. J Allergy Clin Immunol (2001) 0.91
Allele-specific expression of the murine Ren-1 genes. J Biol Chem (1989) 0.91
Cytoplasmic localization of cyclin D3 in seminiferous tubules during testicular development. Exp Cell Res (1997) 0.90
Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development. J Mol Cell Cardiol (1998) 0.89
Two Ustilago maydis viral dsRNAs of different size code for the same product. Nucleic Acids Res (1983) 0.89
Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility. J Mol Cell Cardiol (1998) 0.88
Renal tubule regeneration after ischemic injury is coupled to the up-regulation and activation of cyclins and cyclin dependent kinases. Kidney Int (1997) 0.87
The seventh Korea-Japan joint symposium on cancer and ageing research: molecular targets in cancer and ageing research. J Cancer Res Clin Oncol (2006) 0.87
Temporal expressions of cyclins and cyclin dependent kinases during renal development and compensatory growth. Kidney Int (1997) 0.86
Cardiac repair by embryonic stem-derived cells. Handb Exp Pharmacol (2006) 0.85
Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes. J Mol Cell Cardiol (2001) 0.85
Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett (1999) 0.85
Evaluation of numerical sediment quality targets for the St. Louis River Area of Concern. Arch Environ Contam Toxicol (2002) 0.85
Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets. Am J Physiol (1995) 0.85
Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor. Circ Res (1994) 0.84
Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J Physiol (1992) 0.83
Spontaneous activity in transgenic mouse heart: comparison of primary atrial tumor with cultured AT-1 atrial myocytes. J Cardiovasc Electrophysiol (1993) 0.83
Residues 2-25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic reticulum. J Biol Chem (1993) 0.82
Potential approaches for myocardial regeneration. Ann N Y Acad Sci (1995) 0.82
Amplified CDK2 and cdc2 activities in primary colorectal carcinoma. Cancer (1999) 0.82
Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis. Nephron (1997) 0.82
Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice. Transplantation (1994) 0.81
Characteristics of distension-induced release of immunoreactive atrial natriuretic peptide in isolated perfused rabbit atria. Regul Pept (1988) 0.81
Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product. Cell Mol Biol Res (1995) 0.81
Developmental expression of p107 mRNA and evidence for alternative splicing of the p107 (RBL1) gene product. Genomics (1995) 0.81
Sustained cardiomyocyte DNA synthesis in whole embryo cultures lacking the TSC2 gene product. Am J Physiol (1997) 0.80
Sequential mechanism of atrial natriuretic peptide secretion in isolated perfused rabbit atria. Biochem Biophys Res Commun (1990) 0.80
Plasma concentration of atrial natriuretic peptide in different phases of Korean hemorrhagic fever. Nephron (1989) 0.80
Mouse RAD50 has limited epitopic homology to p53 and is expressed in the adult myocardium. J Biol Chem (1996) 0.80
Cyclins and cyclin dependent kinases during cardiac development. Mol Cells (1997) 0.80
Single injection of pentobarbital induces long-lasting effects on ANP synthesis and gene expression in the rat atria. Life Sci (1993) 0.79